Genetic Test for Opioid Addiction Risk Should Be Withdrawn, Experts Tell FDA

(MedPage Today) -- A group of 31 physicians and researchers called on the FDA to reverse its decision about AvertD, a test that uses DNA to identify whether adults may have an elevated risk of developing opioid use disorder (OUD). In a letter...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news